Enanta Pharmaceuticals In... (ENTA)
5.30
-0.22 (-3.99%)
At close: Apr 01, 2025, 3:59 PM
5.36
1.07%
After-hours: Apr 01, 2025, 07:50 PM EDT
Enanta Pharmaceuticals Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -116.05M | -133.82M | -121.75M | -79M | -36.17M | 46.38M | 71.96M | 17.71M | 21.67M | 78.99M | 34.44M | 9.63M | 21.4M | 23.31M | 7.9M |
| Depreciation & Amortization | 2.34M | 2.37M | 2.97M | 3.33M | 3.64M | 3.26M | 2.52M | 2.14M | 1.66M | 639K | 352K | 221K | 172K | 499K | 553K |
| Stock-Based Compensation | 26.8M | 28.22M | 26.97M | 20.99M | 19.57M | 19.23M | 15.85M | 13.07M | 9.35M | 5.84M | 2.68M | 1.06M | 424K | 225K | 259K |
| Other Working Capital | 6.57M | -243K | 8.16M | -17.38M | 2.26M | 291K | -92K | 478K | 397K | 649K | -10K | 15K | 22K | -814K | -20.14M |
| Other Non-Cash Items | 1.02M | 2.6M | 242K | -1.98M | -3.47M | -5.8M | -1.17M | -581K | -749K | -2.99M | 176K | -1.78M | 535K | 2.75M | -480K |
| Deferred Income Tax | n/a | -10.55M | n/a | 345K | 10.61M | -3.14M | 1.86M | -1.65M | -2.29M | 11.03M | -15.21M | 781K | n/a | -360K | n/a |
| Change in Working Capital | 7.13M | 8.02M | 6.79M | -13.69M | 12.9M | 11.49M | -61.79M | 21.97M | 6.17M | -16.83M | -2.26M | 741K | 93K | -2.4M | -18.41M |
| Operating Cash Flow | -78.76M | -103.15M | -84.78M | -70M | 7.09M | 71.42M | 29.22M | 52.65M | 35.81M | 76.67M | 20.18M | 10.65M | 22.62M | 24.02M | -10.18M |
| Capital Expenditures | -17.95M | -9.06M | -2.13M | -750K | -1.45M | -5.42M | -2.98M | -2.51M | -4.74M | -2.34M | -1.03M | -606K | -252K | -445K | -37K |
| Acquisitions | n/a | 44.52M | -54.9M | -37.74M | -21.27M | 86.66M | n/a | n/a | n/a | 9K | n/a | n/a | 66K | 9K | n/a |
| Purchase of Investments | -307.28M | -373.39M | -171.45M | -307.35M | -338.55M | -549.31M | -293.1M | -251.37M | -192.43M | -196.3M | -98.41M | -115.89M | -47.69M | -33.57M | -603K |
| Sales Maturities Of Investments | 383.46M | 328.87M | 228.47M | 345.09M | 359.83M | 468.06M | 260.68M | 249.31M | 153.5M | 110.62M | 99.93M | 47.28M | 28.7M | 16.76M | 2.3M |
| Other Investing Acitivies | n/a | -44.52M | 54.9M | 37.74M | 21.27M | -86.66M | -32.42M | -2.07M | -38.92M | -172K | 3K | -68.61M | 1.14M | -436K | n/a |
| Investing Cash Flow | 58.23M | -53.58M | 54.9M | 36.99M | 19.83M | -86.66M | -35.4M | -4.57M | -43.66M | -88.19M | 497K | -69.22M | -18.04M | -17.68M | 1.66M |
| Debt Repayment | -27.48M | n/a | n/a | n/a | n/a | -86K | -79K | -73K | -68K | n/a | n/a | n/a | n/a | n/a | -7K |
| Common Stock Repurchased | n/a | n/a | -1.23M | -534K | -1.5M | -4.19M | -1.76M | -202K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -147K | 198.13M | 20.03M | 3.08M | 8.98M | 2.66M | 4.49M | 1.09M | 2.77M | 2.54M | 1.16M | -2.98M | -909K | 34K | 15K |
| Financial Cash Flow | -27.63M | 198.13M | 20.03M | 3.08M | 8.98M | 2.57M | 4.41M | 1.02M | 2.71M | 2.54M | 1.16M | 56.91M | -909K | 34K | 8K |
| Net Cash Flow | -48.16M | 41.39M | -9.85M | -29.93M | 35.9M | -12.67M | -1.77M | 49.1M | -5.15M | -8.97M | 21.84M | -1.65M | 3.67M | 6.37M | -8.5M |
| Free Cash Flow | -96.71M | -112.21M | -86.91M | -70.75M | 5.64M | 66M | 26.24M | 50.15M | 31.07M | 74.34M | 19.15M | 10.05M | 22.37M | 23.57M | -10.21M |